Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level

Konstantin Tachkova Department of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaView further author information

Vladimira Boyadzhievab Department of Rheumatology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria;c Rheumatology Clinic, University Hospital St. Ivan Rilski, Sofia, BulgariaView further author information

Ivan Maneva Department of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaView further author information

Nikolay Stoilovb Department of Rheumatology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria;c Rheumatology Clinic, University Hospital St. Ivan Rilski, Sofia, BulgariaView further author information

Zornitsa Mitkovaa Department of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaView further author information

Konstantin Mitova Department of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaView further author information

Guenka Petrovaa Department of Organisation and Economy of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaCorrespondence[email protected]
View further author information

show all

Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date